Key terms

About HRTX

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest HRTX news

Apr 16 1:50pm ET Heron Therapeutics management to meet virtually with Northland by TipRanks Apr 16 4:55am ET Heron Therapeutics management to meet virtually with Northland by TipRanks Apr 10 4:25pm ET Heron Therapeutics management to meet virtually with Northland by TipRanks Mar 21 4:42pm ET Heron Therapeutics Announces New Principal Accounting Officer by TipRanks Mar 15 11:32am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 13 9:41am ET Heron Therapeutics price target raised to $5 from $4 at Needham by TipRanks Mar 13 8:56am ET Northland Securities Keeps Their Buy Rating on Heron Therapeutics (HRTX) by TipRanks Mar 13 6:17am ET Heron Therapeutics: A Strong Buy on Robust Q4 Performance and Promising Revenue Growth Prospects by TipRanks Mar 12 4:11pm ET Heron Therapeutics sees FY24 Adjusted EBITDA ($22.0M)-$3.0M by TipRanks Mar 12 4:08pm ET Heron Therapeutics reports Q4 EPS (7c), consensus (16c) by TipRanks Mar 12 2:19pm ET Heron Therapeutics options imply 11.6% move in share price post-earnings by TipRanks Mar 12 8:05am ET Options Volatility and Implied Earnings Moves Today, March 12, 2024 by TipRanks Jan 26 11:25am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 25 11:38am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 25 11:38am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 25 4:07am ET Heron Therapeutics Gains FDA Nod for ZYNRELEF® Expansion by TipRanks Jan 24 6:46am ET Heron Therapeutics: Strong Buy on Zynrelef’s Market Expansion and Strategic Collaborations by TipRanks Jan 23 8:07pm ET Heron Therapeutics announces FDA approval of ZYNRELEF indication expansion by TipRanks

No recent press releases are available for HRTX

HRTX Financials

1-year income & revenue

Key terms

HRTX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

HRTX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days